Living with IBD and finding hope for the future

2026-06-16T09:17:00+01:0016 June 2026|

Inflammatory bowel disease (IBD) looks different for everyone who has it. We spoke with medical student, Imogen about her personal experience of living with IBD, how it has influenced her career path and how new research from the Wellcome Sanger Institute brings her hope.

Microbiotica: CASE STUDY

2025-01-16T14:21:41+00:001 December 2024|

Based originally upon the research of the human microbiome carried out at the Wellcome Sanger Institute, Microbiotica was spun out as a microbiome therapeutics company in 2016. Today, Microbiotica is advancing steadily towards introducing transformational microbiome-based therapeutics and biomarkers in areas of high medical need, with first clinical trials – underpinned by a landmark £50m investment during 2022 – starting soon.

Correlation is not causation

2024-05-21T14:33:29+01:0017 October 2023|

Meet Dr. Laura Fachal, working on the genetics of Inflammatory Bowel Disease (IBD). Laura told us about her work, being a woman in science, and the researchers who have inspired her.

20 Things We Learned in 2020

2021-11-08T11:50:04+00:0021 December 2020|

This has been a year that none of us will forget in a hurry. The Institute is immensely proud of the way our staff have pulled together, and the work we have managed to achieve